{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:19:11Z","timestamp":1788452351623,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinre.2026.102820","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:55:13Z","timestamp":1774940113000},"page":"102820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["When to suspect monogenic autoinflammatory diseases in patients with digestive symptoms?"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-9074","authenticated-orcid":false,"given":"Rim","family":"Bourguiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Delplanque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Grandpeix-Guyodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilaine","family":"Boursier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Savey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Cuisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2026.102820_bib0001","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0002","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3389\/fimmu.2019.01745","article-title":"The pyrin inflammasome in health and disease","volume":"10","author":"Schnappauf","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinre.2026.102820_bib0003","doi-asserted-by":"crossref","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0004","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-\u03baB in biology and targeted therapy: new insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.clinre.2026.102820_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101975","article-title":"From concept to clinical practice","volume":"38","author":"Mendon\u00e7a","year":"2024","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003211","article-title":"Assessment of type I interferon response in routine practice in France in 2022","volume":"9","author":"Nombel","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.clinre.2026.102820_bib0008","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3899\/jrheum.2024-0294","article-title":"Children with type I interferonopathy: commonalities and diversities in a large patient cohort","volume":"51","author":"Haslak","year":"2024","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0009","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2022018486","article-title":"DOCK11 deficiency in patients with X-linked actinopathy and autoimmunity","author":"Boussard","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.clinre.2026.102820_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.revmed.2023.06.005","article-title":"Revue de la litt\u00e9rature sur les syndromes auto-inflammatoires monog\u00e9niques li\u00e9s aux actinopathies","volume":"44","author":"Mertz","year":"2023","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103715","article-title":"Current landscape of monogenic autoinflammatory actinopathies: a literature review","volume":"24","author":"Mertz","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clinre.2026.102820_bib0012","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","article-title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever","volume":"74","author":"Giancane","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0013","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5152\/TurkArchPediatr.2024.24188","article-title":"Familial Mediterranean fever in childhood","volume":"59","author":"Ekinci","year":"2024","journal-title":"Turk Arch Pediatr"},{"key":"10.1016\/j.clinre.2026.102820_bib0014","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/BOR.0000000000000315","article-title":"Familial Mediterranean fever","volume":"28","author":"Padeh","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejim.2022.09.028","article-title":"Georgin-Lavialle S. Identification of factors for persistence of AA amyloidosis in patients with Familial Mediterranean fever","volume":"108","author":"Terr\u00e9","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0016","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.revmed.2022.12.004","article-title":"French practical guidelines for the diagnosis and management of AA amyloidosis","volume":"44","author":"Georgin-Lavialle","year":"2023","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0017","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0018","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/1756-185X.13396","article-title":"Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever","volume":"21","author":"Gucenmez","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0019","first-page":"S104","article-title":"Therapeutic approach to patients with familial Mediterranean fever-related amyloidosis resistant to colchicine","volume":"30","author":"Korkmaz","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2017.03.006","article-title":"Colchicine resistance and intolerance in familial mediterranean fever: definition, causes, and alternative treatments","volume":"47","author":"Ozen","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinre.2026.102820_bib0021","first-page":"97","article-title":"Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?","volume":"36","author":"Erden","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0022","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0023","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ard.2025.01.028","article-title":"EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update","volume":"84","author":"Ozen","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0024","doi-asserted-by":"crossref","DOI":"10.55563\/clinexprheumatol\/cj61ub","article-title":"A single dose of anakinra for arresting familial Mediterranean fever attacks: a proof-of-concept study","author":"Giat","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jaip.2024.11.025","article-title":"Performance of serum IL-18 levels for the follow-up of patients with familial Mediterranean fever","volume":"13","author":"Elhani","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clinre.2026.102820_bib0026","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.revmed.2017.09.002","article-title":"Cryopyrinopathies","volume":"39","author":"Quartier","year":"2018","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0027","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s41927-022-00321-8","article-title":"A unique presentation of NLRP3-associated autoinflammatory disease: case report","volume":"6","author":"Ducharme-B\u00e9nard","year":"2022","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0029","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/10408363.2018.1488805","article-title":"Mosaicism in autoinflammatory diseases: cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review","volume":"55","author":"Labrousse","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.clinre.2026.102820_bib0030","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1093\/rheumatology\/keac145","article-title":"AA amyloidosis complicating cryopyrin-associated periodic syndrome: a study of 86 cases including 23 French patients and systematic review","volume":"61","author":"Rodrigues","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinre.2026.102820_bib0031","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102820_bib0032","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0033","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.39960","article-title":"Identification of a high-frequency somatic NLRC4 mutation as a cause of autoinflammation by pluripotent cell\u2013based phenotype dissection","volume":"69","author":"Kawasaki","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0034","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.revmed.2018.02.003","article-title":"Les maladies auto-inflammatoires associ\u00e9es aux mutations de NLRC4 : revue syst\u00e9matique de la litt\u00e9rature","volume":"39","author":"Rodrigues","year":"2018","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0035","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102820_bib0036","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.revmed.2024.08.003","article-title":"Maladies auto-inflammatoires associ\u00e9es \u00e0 l\u2019IL-18","volume":"46","author":"Mertz","year":"2025","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0037","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.clinre.2026.102820_bib0038","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.revmed.2018.02.002","article-title":"La fi\u00e8vre r\u00e9currente li\u00e9e au r\u00e9cepteur 1 du TNF (TNF receptor associated periodic syndrome, TRAPS)","volume":"39","author":"Georgin-Lavialle","year":"2018","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0039","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"73","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0040","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.1093\/rheumatology\/keab252","article-title":"Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review","volume":"60","author":"Delaleu","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinre.2026.102820_bib0041","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejim.2024.01.034","article-title":"Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome","volume":"123","author":"Terr\u00e9","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0042","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00296-015-3305-2","article-title":"Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)","volume":"35","author":"La Torre","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clinre.2026.102820_bib0043","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/rheumatology\/kev111","article-title":"On-demand treatment with anakinra: a treatment option for selected TRAPS patients: fig. 1","volume":"54","author":"Grimwood","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.clinre.2026.102820_bib0044","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/1756-185X.12521","article-title":"Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant","volume":"18","author":"Cantarini","year":"2015","journal-title":"Int J of Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0045","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the eurofever registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0046","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.semarthrit.2020.03.005","article-title":"AA amyloidosis revealing mevalonate kinase deficiency: a report of 20 cases including two new French cases and a comprehensive review of literature","volume":"50","author":"Rodrigues","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinre.2026.102820_bib0047","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3899\/jrheum.170684","article-title":"Efficacy of continuous IL 1 blockade in mevalonate kinase deficiency: a multicenter retrospective study in 13 adult patients and literature review","volume":"45","author":"Deshayes","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0048","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"Ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0049","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/RHU.0000000000001905","article-title":"VEXAS syndrome\u2014a review of pathophysiology, presentation, and prognosis","volume":"29","author":"Koster","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0050","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients*","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0051","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ajh.27156","article-title":"VEXAS syndrome: clinical, hematologic features and a practical approach to diagnosis and management","volume":"99","author":"Koster","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinre.2026.102820_bib0052","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/S2352-3026(23)00375-7","article-title":"Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond","volume":"11","author":"Lacombe","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clinre.2026.102820_bib0053","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/ard-2023-224819","article-title":"Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry","volume":"83","author":"De Valence","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0054","doi-asserted-by":"crossref","first-page":"ofae405","DOI":"10.1093\/ofid\/ofae405","article-title":"Opportunistic infections, mortality risk, and prevention strategies in patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome","volume":"11","author":"Czech","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.reuma.2023.10.006","article-title":"VEXAS syndrome: clinical manifestations, diagnosis, and treatment","volume":"20","author":"Loeza-Uribe","year":"2024","journal-title":"Reumatol Cl\u00edn"},{"key":"10.1016\/j.clinre.2026.102820_bib0056","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/ard-2024-225640","article-title":"Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX","volume":"83","author":"Hadjadj","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinre.2026.102820_bib0057","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.clinre.2026.102820_bib0058","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jid.2023.12.007","article-title":"Haploinsufficiency: a systematic review of 177 cases","volume":"144","author":"Elhani","year":"2024","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0059","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.revmed.2023.12.004","article-title":"L\u2019haploinsuffisance de A20 : que doit conna\u00eetre le clinicien?","volume":"45","author":"Elhani","year":"2024","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0060","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.revmed.2022.06.005","article-title":"Revue de la litt\u00e9rature sur les maladies auto-inflammatoires associ\u00e9es aux mutations du g\u00e8ne RIPK1","volume":"43","author":"Parentelli","year":"2022","journal-title":"Rev M\u00e9d Interne"},{"key":"10.1016\/j.clinre.2026.102820_bib0061","first-page":"810","article-title":"Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation","volume":"361","author":"Cuchet-Louren\u00e7o","year":"2018","journal-title":"Science (1979)"},{"key":"10.1016\/j.clinre.2026.102820_bib0062","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","article-title":"A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1","volume":"577","author":"Tao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2026.102820_bib0063","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","article-title":"Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease","volume":"577","author":"Lalaoui","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clinre.2026.102820_bib0064","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20160724","article-title":"Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration","volume":"214","author":"Badran","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0065","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaci.2019.11.051","article-title":"Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"146","author":"Lorenzini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinre.2026.102820_bib0066","article-title":"Individuals with JAK1 variants are affected by syndromic features encompassing autoimmunity, atopy, colitis, and dermatitis","volume":"221","author":"Horesh","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0067","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.jaci.2016.12.957","article-title":"JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome","volume":"139","author":"Del Bel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinre.2026.102820_bib0068","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jaci.2023.06.004","article-title":"Successful treatment of JAK1-associated inflammatory disease","volume":"152","author":"Fayand","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinre.2026.102820_bib0069","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0071","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0072","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.semarthrit.2021.09.001","article-title":"DADA2 diagnosed in adulthood versus childhood: a comparative study on 306 patients including a systematic literature review and 12 French cases","volume":"51","author":"Fayand","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinre.2026.102820_bib0073","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.15894","article-title":"Evaluation and management of deficiency of adenosine deaminase 2: an international consensus statement","volume":"6","author":"Lee","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinre.2026.102820_bib0074","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0075","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clinre.2026.102820_bib0076","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0077","doi-asserted-by":"crossref","first-page":"e2175","DOI":"10.1002\/mgg3.2175","article-title":"Clinical characteristics and genotype analysis of a Chinese patient with juvenile arthritis due to novel LACC1 frameshift mutation and literature review","volume":"11","author":"Wu","year":"2023","journal-title":"Mol Genet Genom Med"},{"key":"10.1016\/j.clinre.2026.102820_bib0078","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40272-023-00615-5","article-title":"Practical approach to diagnosis and management of IL-1-mediated autoinflammatory diseases (CAPS, TRAPS, MKD, and DIRA)","volume":"26","author":"Cetin Gedik","year":"2024","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.clinre.2026.102820_bib0079","doi-asserted-by":"crossref","first-page":"638","DOI":"10.46497\/ArchRheumatol.2022.9437","article-title":"Two siblings with Majeed syndrome and neutropenia","volume":"37","author":"Kasap Cuceoglu","year":"2022","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.clinre.2026.102820_bib0080","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3390\/jcm10091963","article-title":"Syndrome of Undifferentiated Recurrent Fever (SURF): an emerging group of autoinflammatory recurrent fevers","volume":"10","author":"Papa","year":"2021","journal-title":"J Clin Med"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:40:38Z","timestamp":1788450038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2210740126000677"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102820","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When to suspect monogenic autoinflammatory diseases in patients with digestive symptoms?","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102820","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102820"}}